Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2024		129,205,901
Beginning balance at Dec. 31, 2024	$ 395,737	$ 129	$ 430,791	$ (35,199)	$ 16
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in connection with employee stock plans (in shares)		500,830
Shares issued in connection with employee stock plans	39	$ 1	38
Shares of Common Stock withheld related to net share settlement (in shares)		(29,006)
Shares of Common Stock withheld related to net share settlement	(129)		(129)
Repurchase of shares (in shares)		(2,078,583)
Repurchase of shares	(10,627)	$ (2)	(10,625)
Stock-based compensation	6,630		6,630
Unrealized loss on marketable securities	(65)				(65)
Foreign currency translation adjustment, net of tax	(560)				(560)
Net loss	(11,402)			(11,402)
Ending balance (in shares) at Mar. 31, 2025		127,599,142
Ending balance at Mar. 31, 2025	379,623	$ 128	426,705	(46,601)	(609)
Beginning balance (in shares) at Dec. 31, 2025		128,550,136
Beginning balance at Dec. 31, 2025	341,739	$ 129	441,107	(101,738)	2,241
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in connection with employee stock plans (in shares)		647,968
Shares issued in connection with employee stock plans	21	$ 1	20
Shares of Common Stock withheld related to net share settlement (in shares)		(55,517)
Shares of Common Stock withheld related to net share settlement	(239)	$ (1)	(238)
Stock-based compensation	4,861		4,861
Unrealized loss on marketable securities	(201)				(201)
Foreign currency translation adjustment, net of tax	328				328
Net loss	(18,866)			(18,866)
Ending balance (in shares) at Mar. 31, 2026		129,142,587
Ending balance at Mar. 31, 2026	$ 327,644	$ 129	$ 445,750	$ (120,604)	$ 2,369